Andrea Wahner Hendrickson MD in Rochester, Minnesota

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: University Of Minnesota Medical School
Graduation Year: 2005
The Primary Medical Specialty for Andrea Wahner Hendrickson MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 19
PAC (PECOS ID)#: 7911901061
NPI #: 1609883321
NPI Created On: 08/02/2006
NPI Last Updated Listed as: 08/21/2020
Primary Taxonomy Code: 207R00000X
License Number:
48789
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medica Health Plans of Wisconsin
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Hydration infusion into a vein
2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
6. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
7. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
8. Infusion of different chemotherapy drug or substance into a vein
9. Infusion of chemotherapy into a vein up to 1 hour
10. Infusion of chemotherapy into a vein
11. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
12. Established patient office or other outpatient visit, typically 5 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Established patient office or other outpatient, visit typically 40 minutes
16. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
17. Injection, atropine sulfate, 0.01 mg
18. Injection, leucovorin calcium, per 50 mg
19. Injection, dexamethasone sodium phosphate, 1 mg
20. Injection, diphenhydramine hcl, up to 50 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).